{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:50:06Z","timestamp":1791341406246,"version":"4.3.1"},"reference-count":249,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001740"],"award-info":[{"award-number":["82001740"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020771","name":"Natural Science Foundation for Young Scientists of Shanxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"publisher","award":["202203021221269"],"award-info":[{"award-number":["202203021221269"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116440","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T08:38:55Z","timestamp":1711010335000},"page":"116440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Exploring the therapeutic potential of regulatory T cell in rheumatoid arthritis: Insights into subsets, markers, and signaling pathways"],"prefix":"10.1016","volume":"174","author":[{"given":"Qin-Yi","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Qing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1341-7588","authenticated-orcid":false,"given":"Sheng-Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biopha.2024.116440_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.biopha.2024.116440_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020378","article-title":"The novel synthetic peptide AESIS-1 exerts a preventive effect on collagen-induced arthritis mouse model via STAT3 suppression","volume":"21","author":"Kim","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2024.116440_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061304","article-title":"Serum biomarkers for discrimination between hepatitis C-related arthropathy and early rheumatoid arthritis","volume":"18","author":"Silosi","year":"2017","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib4","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.7150\/thno.66905","article-title":"Ultrasound imaging tracking of mesenchymal stem cells intracellularly labeled with biosynthetic gas vesicles for treatment of rheumatoid arthritis","volume":"12","author":"Gong","year":"2022","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.biopha.2024.116440_bib5","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.4049\/jimmunol.1401635","article-title":"Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation","volume":"194","author":"Toniolo","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ebiom.2019.08.073","article-title":"Meta-analysis of preclinical studies of mesenchymal stromal cells to treat rheumatoid arthritis","volume":"47","author":"Liu","year":"2019","journal-title":"EBioMedicine"},{"issue":"19","key":"10.1016\/j.biopha.2024.116440_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194731","article-title":"Associations between monocyte and T cell cytokine profiles in autism spectrum disorders: effects of dysregulated innate immune responses on adaptive responses to recall antigens in a subset of ASD children","volume":"20","author":"Jyonouchi","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/biom10010055","article-title":"Decreased H19, GAS5, and linc0597 Expression and association analysis of related gene polymorphisms in rheumatoid arthritis","volume":"10","author":"Wu","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2024.116440_bib9","article-title":"Molecular characterization and functional analysis of DIGIRR from golden pompano (Trachinotus ovatus)","volume":"13","author":"Xie","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaut.2019.02.006","article-title":"AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells","volume":"100","author":"Bing","year":"2019","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.biopha.2024.116440_bib11","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.immuni.2015.05.016","article-title":"E3 Ubiquitin ligase VHL regulates hypoxia-inducible factor-1alpha to maintain regulatory T cell stability and suppressive capacity","volume":"42","author":"Lee","year":"2015","journal-title":"Immunity"},{"issue":"67","key":"10.1016\/j.biopha.2024.116440_bib12","first-page":"eabk0182","article-title":"Effector memory CD4(+) T cells induce damaging innate inflammation and autoimmune pathology by engaging CD40 and TNFR on myeloid cells","volume":"7","author":"McDaniel","year":"2022","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116440_bib13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116440_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12016-016-8590-3","article-title":"Epigenetic variability of CD4+CD25+ Tregs contributes to the pathogenesis of autoimmune diseases","volume":"52","author":"Shu","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116440_bib15","first-page":"5366","article-title":"Decreased regulatory T-cell frequency and interleukin-35 levels in patients with rheumatoid arthritis","volume":"16","author":"Zhang","year":"2018","journal-title":"Exp. Ther. Med"},{"issue":"10","key":"10.1016\/j.biopha.2024.116440_bib16","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0024-3205(97)00602-4","article-title":"Positive correlation between levels of IL-1 or IL-2 and 1,25(OH)2D\/25-OH-D ratio in synovial fluid of patients with rheumatoid arthritis","volume":"61","author":"Inaba","year":"1997","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.biopha.2024.116440_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162306","article-title":"The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis","volume":"11","author":"Morita","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00018-021-04076-2","article-title":"Membrane-bound IL-6R is upregulated on Th17 cells and inhibits Treg cell migration by regulating post-translational modification of VASP in autoimmune arthritis","volume":"79","author":"Yan","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2024.116440_bib19","article-title":"Function and Role of Regulatory T Cells in Rheumatoid Arthritis","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211011370","article-title":"Low-dose IL-2 therapy limits the reduction in absolute numbers of circulating regulatory T cells in rheumatoid arthritis","volume":"13","author":"Zhang","year":"2021","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.biopha.2024.116440_bib21","article-title":"Low-dose IL-2 improved clinical symptoms by restoring reduced regulatory T cells in patients with refractory rheumatoid arthritis: A randomized controlled trial","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib22","article-title":"Characteristics of the Gut Microbiome and Its Relationship With Peripheral CD4(+) T Cell Subpopulations and Cytokines in Rheumatoid Arthritis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.biopha.2024.116440_bib23","doi-asserted-by":"crossref","first-page":"7684352","DOI":"10.1155\/2019\/7684352","article-title":"Low-Dose Sirolimus Immunoregulation Therapy in Patients with Active Rheumatoid Arthritis: A 24-Week Follow-Up of the Randomized, Open-Label, Parallel-Controlled Trial","volume":"2019","author":"Wen","year":"2019","journal-title":"J. Immunol. Res"},{"issue":"8","key":"10.1016\/j.biopha.2024.116440_bib24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.humimm.2015.06.015","article-title":"TGF-beta1-induced regulatory T cells.","volume":"76","author":"Hadaschik","year":"2015","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116440_bib25","first-page":"75","article-title":"Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy","volume":"197","author":"Wiersinga","year":"1988","journal-title":"Ophthalmologica"},{"issue":"10","key":"10.1016\/j.biopha.2024.116440_bib26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00018-022-04563-0","article-title":"Regulatory T cells in rheumatoid arthritis: functions, development, regulation, and therapeutic potential","volume":"79","author":"Yan","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2024.116440_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.947636","article-title":"Migration and homeostasis of regulatory T cells in rheumatoid arthritis","volume":"13","author":"Kotschenreuther","year":"2022","journal-title":"Front Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116440_bib28","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12160","article-title":"tTregs, pTregs, and iTregs: similarities and differences","volume":"259","author":"Shevach","year":"2014","journal-title":"Immunol. Rev."},{"issue":"19","key":"10.1016\/j.biopha.2024.116440_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197015","article-title":"Treg Enhancing Therapies to Treat Autoimmune Diseases","volume":"21","author":"Eggenhuizen","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116440_bib31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.smim.2011.07.005","article-title":"Type 1 regulatory T cells (Tr1) in autoimmunity","volume":"23","author":"Pot","year":"2011","journal-title":"Semin Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/805875","article-title":"The role of different subsets of regulatory T cells in immunopathogenesis of rheumatoid arthritis","volume":"2012","author":"Gol-Ara","year":"2012","journal-title":"Arthritis"},{"issue":"8","key":"10.1016\/j.biopha.2024.116440_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080939","article-title":"Transcriptional Regulation of Differentiation and Functions of Effector T Regulatory Cells","volume":"8","author":"Koizumi","year":"2019","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.biopha.2024.116440_bib34","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1002\/eji.200939392","article-title":"CD46-induced human Treg enhance B-cell responses","volume":"39","author":"Fuchs","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/bs.pmbts.2015.08.005","article-title":"Development and function of effector regulatory T cells","volume":"136","author":"Teh","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"27","key":"10.1016\/j.biopha.2024.116440_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2121520119","article-title":"Differentiation and homeostasis of effector Treg cells are regulated by inositol polyphosphates modulating Ca(2+) influx","volume":"119","author":"Min","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2024.116440_bib37","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.3389\/fimmu.2019.02486","article-title":"Foxp3 Post-translational Modifications and Treg Suppressive Activity","volume":"10","author":"Deng","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.911151","article-title":"Nature vs. nurture: FOXP3, genetics, and tissue environment shape Treg function","volume":"13","author":"Raugh","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib39","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.3389\/fimmu.2019.03136","article-title":"Molecular Mechanisms Controlling Foxp3 Expression in Health and Autoimmunity: From Epigenetic to Post-translational Regulation","volume":"10","author":"Colamatteo","year":"2019","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2177\/jsci.39.51","article-title":"The effects of TGF-betas on immune responses","volume":"39","author":"Komai","year":"2016","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"issue":"69","key":"10.1016\/j.biopha.2024.116440_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi4613","article-title":"Transforming growth factor-beta1 in regulatory T cell biology","volume":"7","author":"Moreau","year":"2022","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib42","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1038\/s41598-022-07075-w","article-title":"Local inhibition of TGF-beta1 signaling improves Th17\/Treg balance but not joint pathology during experimental arthritis.","volume":"12","author":"Aarts","year":"2022","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2024.116440_bib43","doi-asserted-by":"crossref","first-page":"513","DOI":"10.14348\/molcells.2022.2056","article-title":"Current Understanding of Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Signaling in T-Cell Biology and Disease Therapy","volume":"45","author":"Kim","year":"2022","journal-title":"Mol. Cells"},{"issue":"2","key":"10.1016\/j.biopha.2024.116440_bib44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.192.2.303","article-title":"Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4","volume":"192","author":"Takahashi","year":"2000","journal-title":"J. Exp. Med"},{"issue":"29","key":"10.1016\/j.biopha.2024.116440_bib45","doi-asserted-by":"crossref","first-page":"10113","DOI":"10.1073\/pnas.0711106105","article-title":"Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation","volume":"105","author":"Onishi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5899","key":"10.1016\/j.biopha.2024.116440_bib46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.biopha.2024.116440_bib47","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nri2163","article-title":"IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation","volume":"7","author":"Puccetti","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116440_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103085","article-title":"Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases","volume":"21","author":"Gertel","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2024.116440_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003776","article-title":"Phase I\/II study of the LAG-3 inhibitor ieramilimab (LAG525) +\/- anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies","volume":"10","author":"Schoffski","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib50","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.biopha.2024.116440_bib51","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2004.08.010","article-title":"Role of LAG-3 in regulatory T cells","volume":"21","author":"Huang","year":"2004","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib52","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1080\/08820139.2018.1458107","article-title":"LAG-3 Represents a Marker of CD4+ T Cells with Regulatory Activity in Patients with Bone Fracture","volume":"47","author":"Wang","year":"2018","journal-title":"Immunol. Invest"},{"issue":"10","key":"10.1016\/j.biopha.2024.116440_bib53","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1089\/dna.2017.3771","article-title":"Overexpression of Lymphocyte Activation Gene-3 Inhibits Regulatory T Cell Responses in Osteoarthritis","volume":"36","author":"Xia","year":"2017","journal-title":"DNA Cell Biol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib54","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/jmv.27593","article-title":"Assessment of CD39 expression in regulatory T-cell subsets by disease severity in adult and juvenile COVID-19 cases","volume":"94","author":"Simsek","year":"2022","journal-title":"J. Med Virol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116440_bib55","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/ni.3868","article-title":"Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor","volume":"18","author":"Maj","year":"2017","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116440_bib56","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","article-title":"Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression","volume":"110","author":"Borsellino","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.biopha.2024.116440_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095166","article-title":"Revealing the Immune Heterogeneity between Systemic Lupus Erythematosus and Rheumatoid Arthritis Based on Multi-Omics Data Analysis","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib58","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1038\/s41467-018-05872-4","article-title":"Immunomodulatory role of Keratin 76 in oral and gastric cancer","volume":"9","author":"Sequeira","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib59","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13048-021-00867-0","article-title":"The abnormal level of HSP70 is related to Treg\/Th17 imbalance in PCOS patients","volume":"14","author":"Yang","year":"2021","journal-title":"J. Ovarian Res"},{"key":"10.1016\/j.biopha.2024.116440_bib60","article-title":"Natural Killer Cells Infiltration in the Joints Exacerbates Collagen-Induced Arthritis","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib61","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3389\/fimmu.2018.01947","article-title":"The Cytotoxic Activity of Natural Killer Cells Is Suppressed by IL-10(+) Regulatory T Cells During Acute Retroviral Infection","volume":"9","author":"Littwitz-Salomon","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib62","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fimmu.2015.00571","article-title":"The interplay between monocytes\/macrophages and CD4(+) T cell subsets in Rheumatoid arthritis","volume":"6","author":"Roberts","year":"2015","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib63","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3389\/fimmu.2018.01625","article-title":"Expanded Regulatory T Cells induce alternatively activated monocytes with a reduced capacity to expand T helper-17 cells","volume":"9","author":"Romano","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib64","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720954134","article-title":"Therapeutic Effect of Exogenous Regulatory T Cells on Collagen-induced Arthritis and Rheumatoid Arthritis","volume":"29","author":"Li","year":"2020","journal-title":"Cell Transpl."},{"key":"10.1016\/j.biopha.2024.116440_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.939265","article-title":"Evaluation of the immune feature of ACPA-negative rheumatoid arthritis and the clinical value of matrix metalloproteinase-3","volume":"13","author":"Liang","year":"2022","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib66","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/berh.2001.0187","article-title":"The balance of Th1\/Th2 cytokines in rheumatoid arthritis","volume":"15","author":"Schulze-Koops","year":"2001","journal-title":"Best. Pr. Res Clin. Rheuma"},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib67","doi-asserted-by":"crossref","first-page":"628","DOI":"10.5966\/sctm.2015-0299","article-title":"Development of a Functional Biomarker for Use in Cell-Based Therapy Studies in Seropositive Rheumatoid Arthritis","volume":"5","author":"Shalev-Malul","year":"2016","journal-title":"Stem Cells Transl. Med"},{"issue":"4","key":"10.1016\/j.biopha.2024.116440_bib68","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.4049\/jimmunol.1000108","article-title":"Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology","volume":"185","author":"Ernst","year":"2010","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116440_bib69","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.it.2008.12.002","article-title":"T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response","volume":"30","author":"Sitkovsky","year":"2009","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib70","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.4049\/jimmunol.177.5.2765","article-title":"Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis","volume":"177","author":"Naganuma","year":"2006","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116440_bib71","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41419-021-03562-6","article-title":"Protectin DX restores Treg\/T(h)17 cell balance in rheumatoid arthritis by inhibiting NLRP3 inflammasome via miR-20a.","volume":"12","author":"Jin","year":"2021","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.biopha.2024.116440_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123488","article-title":"Immunomodulatory Effects Associated with Cladribine Treatment","volume":"10","author":"Fissolo","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.biopha.2024.116440_bib73","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.biopha.2024.116440_bib74","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.imlet.2019.08.009","article-title":"ATP and adenosine: Role in the immunopathogenesis of rheumatoid arthritis","volume":"214","author":"da Silva","year":"2019","journal-title":"Immunol. Lett."},{"issue":"26","key":"10.1016\/j.biopha.2024.116440_bib75","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.2174\/1381612825666190716145206","article-title":"Role and Function of Adenosine and its Receptors in Inflammation, Neuroinflammation, IBS, Autoimmune Inflammatory Disorders, Rheumatoid Arthritis and Psoriasis","volume":"25","author":"Shakya","year":"2019","journal-title":"Curr. Pharm. Des."},{"issue":"15","key":"10.1016\/j.biopha.2024.116440_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512323","article-title":"Significance of Th17 and Treg in Treatment Efficacy and Outcome in Pediatric Acute Lymphoblastic Leukemia","volume":"24","author":"Kretowska-Grunwald","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2024.116440_bib77","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1111\/jcmm.14554","article-title":"Regulatory T cells protected against abdominal aortic aneurysm by suppression of the COX-2 expression","volume":"23","author":"Liu","year":"2019","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2024.116440_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110093","article-title":"\"To be or not to Be\": Regulatory T cells in melanoma","volume":"118","author":"Ibrahim","year":"2023","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.116440_bib79","doi-asserted-by":"crossref","first-page":"1263537","DOI":"10.3389\/fimmu.2023.1263537","article-title":"Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116440_bib80","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41590-024-01746-8","article-title":"Targeting JMJD1C to selectively disrupt tumor T(reg) cell fitness enhances antitumor immunity.","volume":"25","author":"Long","year":"2024","journal-title":"Nat. Immunol."},{"issue":"44","key":"10.1016\/j.biopha.2024.116440_bib81","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.biopha.2024.116440_bib82","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/jcp.25016","article-title":"Treg(s) in Cancer: Friends or Foe?","volume":"230","author":"Wolf","year":"2015","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2024.116440_bib83","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.yjmcc.2019.05.009","article-title":"Disruption of the CCL1-CCR8 axis inhibits vascular Treg recruitment and function and promotes atherosclerosis in mice","volume":"132","author":"Vila-Caballer","year":"2019","journal-title":"J. Mol. Cell Cardiol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116440_bib84","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1080\/15548627.2021.1909833","article-title":"Augmenting ATG14 alleviates atherosclerosis and inhibits inflammation via promotion of autophagosome-lysosome fusion in macrophages","volume":"17","author":"Zhang","year":"2021","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.biopha.2024.116440_bib85","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.immuni.2018.07.015","article-title":"Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution","volume":"49","author":"Proto","year":"2018","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.biopha.2024.116440_bib86","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.119.316461","article-title":"Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression","volume":"127","author":"Sharma","year":"2020","journal-title":"Circ. Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102925","article-title":"Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus","volume":"21","author":"Restivo","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib88","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"Yu","year":"2009","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116440_bib89","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.4049\/jimmunol.1301693","article-title":"Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10\/MARCH1-dependent mechanism","volume":"191","author":"Chattopadhyay","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib90","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41423-018-0168-y","article-title":"Targeting PVR (CD155) and its receptors in anti-tumor therapy","volume":"16","author":"Kucan Brlic","year":"2019","journal-title":"Cell Mol. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116440_bib91","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41590-018-0280-2","article-title":"Regulatory T cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells","volume":"20","author":"Akkaya","year":"2019","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116440_bib92","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jlb.66.2.286","article-title":"Dendritic cells and the pathogenesis of rheumatoid arthritis","volume":"66","author":"Thomas","year":"1999","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.biopha.2024.116440_bib93","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.193.11.1285","article-title":"Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood","volume":"193","author":"Jonuleit","year":"2001","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.biopha.2024.116440_bib94","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.18688.1","article-title":"Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies","volume":"8","author":"Senolt","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.biopha.2024.116440_bib95","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/bs.pmbts.2015.07.021","article-title":"Regulatory T cells in Arthritis","volume":"136","author":"Komatsu","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2024.116440_bib96","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2005-11-4502","article-title":"Activated CD4+CD25+ T cells selectively kill B lymphocytes","volume":"107","author":"Zhao","year":"2006","journal-title":"Blood"},{"issue":"5955","key":"10.1016\/j.biopha.2024.116440_bib97","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1126\/science.1172702","article-title":"CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner","volume":"326","author":"Chaudhry","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.biopha.2024.116440_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.572858","article-title":"Th17\/Treg-Related Transcriptional Factor Expression and Cytokine Profile in Patients With Rheumatoid Arthritis","volume":"11","author":"Paradowska-Gorycka","year":"2020","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib99","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/1573397118666220401145710","article-title":"The Relationship Between FoxP3 and SOCs3 Gene Expressions and Disease Activity in Rheumatoid Arthritis","volume":"19","author":"Tawfeik","year":"2023","journal-title":"Curr. Rheuma Rev."},{"issue":"3","key":"10.1016\/j.biopha.2024.116440_bib100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41401-020-0457-8","article-title":"TGFbeta2-mediated epithelial-mesenchymal transition and NF-kappaB pathway activation contribute to osimertinib resistance.","volume":"42","author":"Jiang","year":"2021","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2024.116440_bib101","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jaut.2019.04.018","article-title":"NF-kappaB-driven miR-34a impairs Treg\/Th17 balance via targeting Foxp3.","volume":"102","author":"Xie","year":"2019","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib102","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s10067-023-06521-y","article-title":"Investigating the correlation of the NF-kappaB and FoxP3 gene expression with the plasma levels of pro- and anti-inflammatory cytokines in rheumatoid arthritis patients.","volume":"42","author":"Roghani","year":"2023","journal-title":"Clin. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib103","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12865-022-00517-0","article-title":"The proportion and phenotypic changes of CD4(+)CD25(-)Foxp3(+) T cells in patients with untreated rheumatoid arthritis.","volume":"23","author":"Ju","year":"2022","journal-title":"BMC Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib104","article-title":"Th1-Like Treg Cells Are Increased But Deficient in Function in Rheumatoid Arthritis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116440_bib105","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1136\/annrheumdis-2013-204228","article-title":"Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood","volume":"74","author":"Wang","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2024.116440_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112658","article-title":"An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1)","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.biopha.2024.116440_bib107","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","article-title":"Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases","volume":"12","author":"Perl","year":"2016","journal-title":"Nat. Rev. Rheuma"},{"issue":"6","key":"10.1016\/j.biopha.2024.116440_bib108","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1096\/fj.14-268409","article-title":"Essential role of mitochondrial energy metabolism in Foxp3(+) T-regulatory cell function and allograft survival","volume":"29","author":"Beier","year":"2015","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.biopha.2024.116440_bib109","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41423-023-01064-3","article-title":"Regulation of CD8(+) T memory and exhaustion by the mTOR signals.","volume":"20","author":"Chen","year":"2023","journal-title":"Cell Mol. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2024.116440_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007428","article-title":"Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration","volume":"14","author":"Jia","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2024.116440_bib111","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fphar.2019.00161","article-title":"Modified Si-Jun-Zi-Tang Attenuates Airway Inflammation in a Murine Model of Chronic Asthma by Inhibiting Teff Cells via the mTORC1 Pathway","volume":"10","author":"Jin","year":"2019","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib112","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40659-018-0205-4","article-title":"Downregulation of TGF-beta1 suppressed proliferation and increased chemosensitivity of ovarian cancer cells by promoting BRCA1\/Smad3 signaling.","volume":"51","author":"Wang","year":"2018","journal-title":"Biol. Res"},{"issue":"2","key":"10.1016\/j.biopha.2024.116440_bib113","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jcmm.12961","article-title":"MicroRNA-98 regulates osteogenic differentiation of human bone mesenchymal stromal cells by targeting BMP2","volume":"21","author":"Zhang","year":"2017","journal-title":"J. Cell Mol. Med"},{"issue":"24","key":"10.1016\/j.biopha.2024.116440_bib114","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1182\/blood-2010-10-312389","article-title":"Smad1 signaling restricts hematopoietic potential after promoting hemangioblast commitment","volume":"117","author":"Cook","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.biopha.2024.116440_bib115","first-page":"6526","article-title":"Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol","volume":"173","author":"Huber","year":"2004"},{"issue":"3","key":"10.1016\/j.biopha.2024.116440_bib116","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/ar2217","article-title":"Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts.","volume":"9","author":"Pohlers","year":"2007","journal-title":"Arthritis Res Ther."},{"issue":"8","key":"10.1016\/j.biopha.2024.116440_bib117","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3858\/emm.2010.42.8.057","article-title":"Synovial fluid of patients with rheumatoid arthritis induces alpha-smooth muscle actin in human adipose tissue-derived mesenchymal stem cells through a TGF-beta1-dependent mechanism","volume":"42","author":"Song","year":"2010","journal-title":"Exp. Mol. Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib118","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/ard.2007.080127","article-title":"Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritis","volume":"68","author":"Verschueren","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"Pt 14","key":"10.1016\/j.biopha.2024.116440_bib119","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1242\/jcs.021394","article-title":"eIF3k regulates apoptosis in epithelial cells by releasing caspase 3 from keratin-containing inclusions","volume":"121","author":"Lin","year":"2008","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116440_bib120","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/cei.12179","article-title":"Transforming growth factor (TGF)-beta signalling is increased in rheumatoid synovium but TGF-beta blockade does not modify experimental arthritis","volume":"174","author":"Gonzalo-Gil","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib121","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3389\/fimmu.2018.01845","article-title":"Transcriptomic Characterization of a Chicken Embryo Model Infected With Duck Hepatitis A Virus Type 1","volume":"9","author":"Xie","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib122","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40104-019-0371-4","article-title":"In vivo and in vitro protective effect of arginine against intestinal inflammatory response induced by Clostridium perfringens in broiler chickens","volume":"10","author":"Zhang","year":"2019","journal-title":"J. Anim. Sci. Biotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116440_bib123","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1021\/acs.jcim.0c01468","article-title":"Targeting the JAK\/STAT Pathway: A Combined Ligand- and Target-Based Approach","volume":"61","author":"Galvez-Llompart","year":"2021","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/j.biopha.2024.116440_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.734652","article-title":"JAK2-STAT Epigenetically Regulates Tolerized Genes in Monocytes in the First Encounter With Gram-Negative Bacterial Endotoxins in Sepsis","volume":"12","author":"Morante-Palacios","year":"2021","journal-title":"Front Immunol."},{"issue":"5-6","key":"10.1016\/j.biopha.2024.116440_bib125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1759720X18776224","article-title":"The role of the JAK\/STAT signal pathway in rheumatoid arthritis","volume":"10","author":"Malemud","year":"2018","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib126","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.semarthrit.2020.10.008","article-title":"The Jak\/STAT pathway: A focus on pain in rheumatoid arthritis","volume":"51","author":"Simon","year":"2021","journal-title":"Semin Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.biopha.2024.116440_bib127","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/annrheumdis-2019-215164","article-title":"Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan","volume":"78","author":"Takeuchi","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib128","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001994","article-title":"Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy","volume":"8","author":"Taylor","year":"2022","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.biopha.2024.116440_bib129","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142205","article-title":"Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata","volume":"6","author":"Dai","year":"2021","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.biopha.2024.116440_bib130","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood-2009-10-246363","article-title":"Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera\/essential thrombocythemia myelofibrosis","volume":"115","author":"Santos","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib131","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12943-017-0687-7","article-title":"Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosis","volume":"16","author":"Chang","year":"2017","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2024.116440_bib132","first-page":"318","article-title":"The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis","volume":"34","author":"Hodge","year":"2016","journal-title":"Clin. Exp. Rheuma"},{"issue":"6","key":"10.1016\/j.biopha.2024.116440_bib133","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.smim.2011.08.003","article-title":"Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27.","volume":"23","author":"Pot","year":"2011","journal-title":"Semin Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib134","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.imlet.2010.11.007","article-title":"IL-27 induces the differentiation of Tr1-like cells from human naive CD4+ T cells via the phosphorylation of STAT1 and STAT3","volume":"136","author":"Wang","year":"2011","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2024.116440_bib135","doi-asserted-by":"crossref","first-page":"709","DOI":"10.17219\/acem\/61034","article-title":"The Activity of JAK\/STAT and NF-kappaB in Patients with Rheumatoid Arthritis.","volume":"25","author":"Swierkot","year":"2016","journal-title":"Adv. Clin. Exp. Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib136","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13075-018-1690-0","article-title":"Enhanced IL-6\/phosphorylated STAT3 signaling is related to the imbalance of circulating T follicular helper\/T follicular regulatory cells in patients with rheumatoid arthritis","volume":"20","author":"Niu","year":"2018","journal-title":"Arthritis Res Ther."},{"issue":"24","key":"10.1016\/j.biopha.2024.116440_bib137","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246275","article-title":"NF-kappaB Signaling Regulates Physiological and Pathological Chondrogenesis.","volume":"20","author":"Jimi","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2024.116440_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071627","article-title":"Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases","volume":"9","author":"Sehnert","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2024.116440_bib139","doi-asserted-by":"crossref","first-page":"1196931","DOI":"10.3389\/fimmu.2023.1196931","article-title":"Targeting transcription factors for therapeutic benefit in rheumatoid arthritis","volume":"14","author":"Balendran","year":"2023","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116440_bib140","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.immuni.2009.09.022","article-title":"Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor","volume":"31","author":"Long","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2024.116440_bib141","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2024.116440_bib142","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DDDT.S349678","article-title":"Matrine Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review","volume":"16","author":"Lin","year":"2022","journal-title":"Drug Des. Devel Ther."},{"issue":"4","key":"10.1016\/j.biopha.2024.116440_bib143","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/ar300","article-title":"in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction","volume":"3","author":"Makarov","year":"2001","journal-title":"Arthritis Res"},{"key":"10.1016\/j.biopha.2024.116440_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108793","article-title":"Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis","volume":"230","author":"Liu","year":"2021","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13075-015-0527-3","article-title":"Non-canonical NF-kappaB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?","volume":"17","author":"Noort","year":"2015","journal-title":"Arthritis Res Ther."},{"issue":"2 Pt C","key":"10.1016\/j.biopha.2024.116440_bib146","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.molimm.2015.07.024","article-title":"TCR signaling to NF-kappaB and mTORC1: Expanding roles of the CARMA1 complex.","volume":"68","author":"Shi","year":"2015","journal-title":"Mol. Immunol."},{"issue":"13","key":"10.1016\/j.biopha.2024.116440_bib147","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1073\/pnas.0400885101","article-title":"Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation","volume":"101","author":"Schmidt-Supprian","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2024.116440_bib148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000051","article-title":"Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery","volume":"7","author":"Barnes","year":"2009","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib149","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4049\/jimmunol.1303237","article-title":"T cell-intrinsic function of the noncanonical NF-kappaB pathway in the regulation of GM-CSF expression and experimental autoimmune encephalomyelitis pathogenesis","volume":"193","author":"Yu","year":"2014","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116440_bib150","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.4049\/jimmunol.172.4.2067","article-title":"NF-kappa B-inducing kinase establishes self-tolerance in a thymic stroma-dependent manner","volume":"172","author":"Kajiura","year":"2004","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116440_bib151","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/cmi.2009.112","article-title":"The complicated role of NF-kappaB in T-cell selection.","volume":"7","author":"Zhu","year":"2010","journal-title":"Cell Mol. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib152","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","article-title":"Notch signaling pathway: architecture, disease, and therapeutics","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib153","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41392-023-01331-9","article-title":"Signaling pathways in rheumatoid arthritis: implications for targeted therapy","volume":"8","author":"Ding","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"17","key":"10.1016\/j.biopha.2024.116440_bib154","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.7150\/thno.26093","article-title":"Inhibition of Notch1 induces population and suppressive activity of regulatory T cell in inflammatory arthritis","volume":"8","author":"Choi","year":"2018","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40164-020-00191-1","article-title":"Complex roles of cAMP-PKA-CREB signaling in cancer","volume":"9","author":"Zhang","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2024.116440_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108113","article-title":"The regulation of PKA signaling in obesity and in the maintenance of metabolic health","volume":"237","author":"London","year":"2022","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2024.116440_bib157","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.imlet.2017.09.009","article-title":"Prostaglandin E(2) restrains human Treg cell differentiation via E prostanoid receptor 2-protein kinase A signaling","volume":"191","author":"Li","year":"2017","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib158","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13287-016-0439-4","article-title":"Bile acid: a potential inducer of colon cancer stem cells","volume":"7","author":"Farhana","year":"2016","journal-title":"Stem Cell Res Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib159","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/03009742.2010.486767","article-title":"Expression of beta-catenin in rheumatoid arthritis fibroblast-like synoviocytes","volume":"40","author":"Xiao","year":"2011","journal-title":"Scand. J. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib160","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41413-022-00231-y","article-title":"Runx1 is a key regulator of articular cartilage homeostasis by orchestrating YAP, TGFbeta, and Wnt signaling in articular cartilage formation and osteoarthritis.","volume":"10","author":"Zhang","year":"2022","journal-title":"Bone Res"},{"issue":"4","key":"10.1016\/j.biopha.2024.116440_bib161","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/ar1203","article-title":"Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus","volume":"6","author":"Alarcon-Riquelme","year":"2004","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.biopha.2024.116440_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102404","article-title":"EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis","volume":"108","author":"Xiao","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.biopha.2024.116440_bib163","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fonc.2020.00227","article-title":"Localization of GPSM2 in the Nucleus of Invasive Breast Cancer Cells Indicates a Poor Prognosis","volume":"10","author":"Deng","year":"2020","journal-title":"Front Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116440_bib164","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.7150\/thno.41712","article-title":"Interleukin 1beta-mediated HOXC10 Overexpression Promotes Hepatocellular Carcinoma Metastasis by Upregulating PDPK1 and VASP.","volume":"10","author":"Dang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2024.116440_bib165","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221100294","article-title":"Cell-based therapies for rheumatoid arthritis: opportunities and challenges","volume":"14","author":"Li","year":"2022","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2024.116440_bib166","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.berh.2014.10.023","article-title":"Mesenchymal stromal cells for treatment of arthritis","volume":"28","author":"Swart","year":"2014","journal-title":"Best. Pr. Res Clin. Rheuma"},{"issue":"8","key":"10.1016\/j.biopha.2024.116440_bib167","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/jcmm.12849","article-title":"A20 plays a critical role in the immunoregulatory function of mesenchymal stem cells","volume":"20","author":"Dang","year":"2016","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2024.116440_bib168","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaut.2019.05.007","article-title":"DNGR1-mediated deletion of A20\/Tnfaip3 in dendritic cells alters T and B-cell homeostasis and promotes autoimmune liver pathology","volume":"102","author":"Das","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.biopha.2024.116440_bib169","doi-asserted-by":"crossref","first-page":"8839625","DOI":"10.1155\/2020\/8839625","article-title":"Human Bone Marrow Mesenchymal Stem\/Stromal Cells Exposed to an Inflammatory Environment Increase the Expression of ICAM-1 and Release Microvesicles Enriched in This Adhesive Molecule: Analysis of the Participation of TNF-alpha and IFN-gamma","volume":"2020","author":"Montesinos","year":"2020","journal-title":"J. Immunol. Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib170","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41598-017-00923-0","article-title":"MMP9 integrates multiple immunoregulatory pathways that discriminate high suppressive activity of human mesenchymal stem cells","volume":"7","author":"Lavini-Ramos","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.biopha.2024.116440_bib171","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121605","article-title":"Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases","volume":"8","author":"Harrell","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biopha.2024.116440_bib172","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/cei\/uxac035","article-title":"Enhancing and stabilization of cord blood regulatory T-cell suppressive function by human mesenchymal stem cell (MSC)-derived exosomes","volume":"208","author":"Zhang","year":"2022","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib173","doi-asserted-by":"crossref","first-page":"3562753","DOI":"10.1155\/2020\/3562753","article-title":"The Sufficient Immunoregulatory Effect of Autologous Bone Marrow-Derived Mesenchymal Stem Cell Transplantation on Regulatory T Cells in Patients with Refractory Rheumatoid Arthritis","volume":"2020","author":"Ghoryani","year":"2020","journal-title":"J. Immunol. Res"},{"key":"10.1016\/j.biopha.2024.116440_bib174","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3389\/fimmu.2020.01912","article-title":"Immunomodulatory Effects of Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol."},{"issue":"28","key":"10.1016\/j.biopha.2024.116440_bib175","article-title":"Cervus and cucumis peptides combined umbilical cord mesenchymal stem cells therapy for rheumatoid arthritis","volume":"99","author":"Qi","year":"2020","journal-title":"Med. (Baltim. )"},{"issue":"9","key":"10.1016\/j.biopha.2024.116440_bib176","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/sctm.18-0031","article-title":"Intravenous Infusion of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Rheumatoid Arthritis: A Phase Ia Clinical Trial","volume":"7","author":"Park","year":"2018","journal-title":"Stem Cells Transl. Med"},{"key":"10.1016\/j.biopha.2024.116440_bib177","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.2147\/DDDT.S225613","article-title":"Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I\/II Study","volume":"13","author":"Wang","year":"2019","journal-title":"Drug Des. Devel Ther."},{"issue":"10","key":"10.1016\/j.biopha.2024.116440_bib178","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/annrheumdis-2020-217798","article-title":"Combination of human umbilical cord mesenchymal stem (stromal) cell transplantation with IFN-gamma treatment synergistically improves the clinical outcomes of patients with rheumatoid arthritis","volume":"79","author":"He","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2024.116440_bib179","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631291","article-title":"Recent Developments in Clinical Applications of Mesenchymal Stem Cells in the Treatment of Rheumatoid Arthritis and Osteoarthritis","volume":"12","author":"Hwang","year":"2021","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116440_bib180","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcyt.2017.12.009","article-title":"Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1\/2 clinical trial","volume":"20","author":"Shadmanfar","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.biopha.2024.116440_bib181","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.biopha.2018.11.056","article-title":"Amelioration of clinical symptoms of patients with refractory rheumatoid arthritis following treatment with autologous bone marrow-derived mesenchymal stem cells: A successful clinical trial in Iran","volume":"109","author":"Ghoryani","year":"2019","journal-title":"Biomed. Pharm."},{"issue":"24","key":"10.1016\/j.biopha.2024.116440_bib182","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1089\/scd.2013.0023","article-title":"Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy","volume":"22","author":"Wang","year":"2013","journal-title":"Stem Cells Dev."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib183","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/annrheumdis-2015-208918","article-title":"Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib\/IIa clinical trial","volume":"76","author":"Alvaro-Gracia","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2024.116440_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108858","article-title":"Emerging therapeutic potential of regulatory T (Treg) cells for rheumatoid arthritis: New insights and challenges","volume":"108","author":"Rezaei Kahmini","year":"2022","journal-title":"Int Immunopharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116440_bib185","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrrheum.2014.105","article-title":"TREG-cell therapies for autoimmune rheumatic diseases","volume":"10","author":"Miyara","year":"2014","journal-title":"Nat. Rev. Rheuma"},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib186","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/art.11063","article-title":"CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis.","volume":"48","author":"Morgan","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2024.116440_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2022.102822","article-title":"Manufacturing next-generation regulatory T-cell therapies","volume":"78","author":"MacDonald","year":"2022","journal-title":"Curr. Opin. Biotechnol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116440_bib188","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/art.21195","article-title":"Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells.","volume":"52","author":"Morgan","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib189","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/ard.2007.086066","article-title":"Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis","volume":"68","author":"Kelchtermans","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2024.116440_bib190","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2337\/dc12-0038","article-title":"Administration of CD4+CD25highCD127- regulatory T cells preserves beta-cell function in type 1 diabetes in children","volume":"35","author":"Marek-Trzonkowska","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib191","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/nyas.13625","article-title":"Regulatory T cells: a potential target in cancer immunotherapy","volume":"1417","author":"Shitara","year":"2018","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.biopha.2024.116440_bib192","doi-asserted-by":"crossref","first-page":"8575407","DOI":"10.1155\/2019\/8575407","article-title":"Efficient Therapeutic Function and Mechanisms of Human Polyclonal CD8(+)CD103(+)Foxp3(+) Regulatory T Cells on Collagen-Induced Arthritis in Mice","volume":"2019","author":"Sun","year":"2019","journal-title":"J. Immunol. Res"},{"issue":"4","key":"10.1016\/j.biopha.2024.116440_bib193","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nri.2016.26","article-title":"T cell receptor signalling in the control of regulatory T cell differentiation and function","volume":"16","author":"Li","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"45","key":"10.1016\/j.biopha.2024.116440_bib194","doi-asserted-by":"crossref","first-page":"19078","DOI":"10.1073\/pnas.0907396106","article-title":"Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis","volume":"106","author":"Wright","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.biopha.2024.116440_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103134","article-title":"New insights for regulatory T cell in lupus nephritis","volume":"21","author":"Li","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2024.116440_bib196","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3389\/fimmu.2018.02359","article-title":"Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116440_bib197","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/annrheumdis-2020-217844","article-title":"In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells","volume":"80","author":"Zhang","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.biopha.2024.116440_bib198","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41584-021-00707-x","article-title":"Interleukin-2 and regulatory T cells in rheumatic diseases","volume":"17","author":"Kolios","year":"2021","journal-title":"Nat. Rev. Rheuma"},{"issue":"4","key":"10.1016\/j.biopha.2024.116440_bib199","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4161\/cc.7.4.5454","article-title":"Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy","volume":"7","author":"Zeiser","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.biopha.2024.116440_bib200","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and Function of Interleukin-2 in T Lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu Rev. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116440_bib201","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib202","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41392-022-00887-2","article-title":"Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib203","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/TP.0000000000000476","article-title":"Rapamycin protection of livers from ischemia and reperfusion injury is dependent on both autophagy induction and mammalian target of rapamycin complex 2-Akt activation","volume":"99","author":"Zhu","year":"2015","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib204","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1189\/jlb.2RI0814-408R","article-title":"mTOR and metabolic regulation of conventional and regulatory T cells","volume":"97","author":"Liu","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116440_bib205","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.biopha.2024.116440_bib206","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2007.078808","article-title":"Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study","volume":"67","author":"Bruyn","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib207","first-page":"58","article-title":"Sirolimus selectively increases circulating Treg cell numbers and restores the Th17\/Treg balance in rheumatoid arthritis patients with low disease activity or in DAS28 remission who previously received conventional disease-modifying anti-rheumatic drugs","volume":"38","author":"Niu","year":"2020","journal-title":"Clin. Exp. Rheuma"},{"key":"10.1016\/j.biopha.2024.116440_bib208","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1749-6632.2003.tb05964.x","article-title":"Histone deacetylases: unique players in shaping the epigenetic histone code","volume":"983","author":"Thiagalingam","year":"2003","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"23","key":"10.1016\/j.biopha.2024.116440_bib209","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1021\/jz301670s","article-title":"Mass Modulation of Protein Dynamics Associated with Barrier Crossing in Purine Nucleoside Phosphorylase","volume":"3","author":"Antoniou","year":"2012","journal-title":"J. Phys. Chem. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib210","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jcp.24680","article-title":"Histone deacetylase inhibition destabilizes the multi-potent state of uncommitted adipose-derived mesenchymal stromal cells","volume":"230","author":"Dudakovic","year":"2015","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib211","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/imcb.12203","article-title":"Histone deacetylase 2 is essential for LPS-induced inflammatory responses in macrophages","volume":"97","author":"Wu","year":"2019","journal-title":"Immunol. Cell Biol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116440_bib212","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/annrheumdis-2014-205635","article-title":"Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression","volume":"75","author":"Angiolilli","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2024.116440_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102379","article-title":"Histone deacetylase 1 (HDAC1): A key player of T cell-mediated arthritis","volume":"108","author":"Goschl","year":"2020","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.biopha.2024.116440_bib214","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00109-015-1332-9","article-title":"Regulation and function of SIRT1 in rheumatoid arthritis synovial fibroblasts","volume":"94","author":"Engler","year":"2016","journal-title":"J. Mol. Med (Berl. )"},{"issue":"Pt A","key":"10.1016\/j.biopha.2024.116440_bib215","article-title":"Regulation of Sirt1 on energy metabolism and immune response in rheumatoid arthritis","volume":"101","author":"Wu","year":"2021","journal-title":"Int Immunopharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib216","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.coi.2011.07.002","article-title":"Histone\/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells","volume":"23","author":"Beier","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116440_bib217","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.yexmp.2009.06.003","article-title":"Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis","volume":"87","author":"Saouaf","year":"2009","journal-title":"Exp. Mol. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib218","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/annrheumdis-2015-209064","article-title":"Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes","volume":"76","author":"Angiolilli","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2024.116440_bib219","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/rheumatology\/kev022","article-title":"Inhibiting histone deacetylase 1 suppresses both inflammation and bone loss in arthritis","volume":"54","author":"Cantley","year":"2015","journal-title":"Rheumatol. (Oxf. )"},{"issue":"7","key":"10.1016\/j.biopha.2024.116440_bib220","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116440_bib221","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/14740338.2019.1615052","article-title":"An updated review of glucocorticoid-related adverse events in patients with rheumatoid arthritis","volume":"18","author":"Luis","year":"2019","journal-title":"Expert Opin. Drug Saf."},{"issue":"4","key":"10.1016\/j.biopha.2024.116440_bib222","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3899\/jrheum.180178","article-title":"Biologic and Glucocorticoid Use after Methotrexate Initiation in Patients with Rheumatoid Arthritis","volume":"46","author":"George","year":"2019","journal-title":"J. Rheuma"},{"key":"10.1016\/j.biopha.2024.116440_bib223","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/310628","article-title":"Efficacy and safety of iguratimod for the treatment of rheumatoid arthritis","volume":"2013","author":"Li","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib224","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/1744666X.2022.2064275","article-title":"Janus kinase versus TNF inhibitors: where we stand today in rheumatoid arthritis","volume":"18","author":"Venetsanopoulou","year":"2022","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.biopha.2024.116440_bib225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115837","article-title":"Gancao Fuzi decoction regulates the Th17\/Treg cell imbalance in rheumatoid arthritis by targeting Foxp3 via miR-34a","volume":"301","author":"Zhao","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2024.116440_bib226","doi-asserted-by":"crossref","first-page":"5105545","DOI":"10.1155\/2022\/5105545","article-title":"Wu-Teng-Gao External Treatment Improves Th17\/Treg Balance in Rheumatoid Arthritis","volume":"2022","author":"Yao","year":"2022","journal-title":"Evid. Based Complement Altern. Med"},{"issue":"17","key":"10.1016\/j.biopha.2024.116440_bib227","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1021\/acs.jafc.0c01473","article-title":"Ginsenoside Rg3 Alleviates Complete Freund's Adjuvant-Induced Rheumatoid Arthritis in Mice by Regulating CD4(+)CD25(+)Foxp3(+)Treg Cells","volume":"68","author":"Zhang","year":"2020","journal-title":"J. Agric. Food Chem."},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib228","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/rheumatology\/keu487","article-title":"The impact of biological therapy on regulatory T cells in rheumatoid arthritis","volume":"54","author":"Byng-Maddick","year":"2015","journal-title":"Rheumatol. (Oxf. )"},{"issue":"7-8","key":"10.1016\/j.biopha.2024.116440_bib229","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s10495-019-01548-6","article-title":"Berberine mitigates IL-21\/IL-21R mediated autophagic influx in fibroblast-like synoviocytes and regulates Th17\/Treg imbalance in rheumatoid arthritis","volume":"24","author":"Dinesh","year":"2019","journal-title":"Apoptosis"},{"issue":"3","key":"10.1016\/j.biopha.2024.116440_bib230","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/rai2.12043","article-title":"Mechanism-driven strategies for prevention of rheumatoid arthritis","volume":"2","author":"Holers","year":"2022","journal-title":"Rheuma Autoimmun."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib231","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000314","article-title":"Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA","volume":"3","author":"Jani","year":"2017","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.biopha.2024.116440_bib232","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008331","article-title":"Tocilizumab for rheumatoid arthritis","author":"Singh","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib233","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/rai2.12022","article-title":"Tocilizumab in rheumatoid arthritis-associated peripheral ulcerative keratitis: A 1-year follow-up case report","volume":"2","author":"Huang J","year":"2022","journal-title":"Rheumatol. Autoimmun."},{"issue":"7090","key":"10.1016\/j.biopha.2024.116440_bib234","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopha.2024.116440_bib235","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrd.2018.45","article-title":"Interleukin-6: designing specific therapeutics for a complex cytokine","volume":"17","author":"Garbers","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.biopha.2024.116440_bib236","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1136\/annrheumdis-2011-201087","article-title":"Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and\/or TNF inhibitors: a large, open-label study close to clinical practice","volume":"71","author":"Bykerk","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2024.116440_bib237","first-page":"94","article-title":"Tocilizumab in patients with active rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs or tumor necrosis factor inhibitors: subanalysis of Spanish results of an open-label study close to clinical practice","volume":"10","author":"Alvaro-Gracia","year":"2014","journal-title":"Reum. Clin."},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib238","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s10067-019-04815-8","article-title":"Safety and efficacy of tocilizumab as monotherapy or in combination with methotrexate in Tunisian patients with active rheumatoid arthritis and inadequate response to disease-modifying anti-rheumatic drugs in conditions close to clinical practice","volume":"39","author":"Bouajina","year":"2020","journal-title":"Clin. Rheuma"},{"issue":"17","key":"10.1016\/j.biopha.2024.116440_bib239","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s40265-017-0829-7","article-title":"Tocilizumab: a review in Rheumatoid arthritis","volume":"77","author":"Scott","year":"2017","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.biopha.2024.116440_bib240","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s10875-011-9527-5","article-title":"CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis","volume":"31","author":"Alvarez-Quiroga","year":"2011","journal-title":"J. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib241","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/mr\/roab090","article-title":"Effectiveness and safety of subcutaneous abatacept in biologic-naive RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study)","volume":"32","author":"Tamura","year":"2022","journal-title":"Mod. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2024.116440_bib242","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13075-021-02607-7","article-title":"HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RA","volume":"23","author":"Rigby","year":"2021","journal-title":"Arthritis Res Ther."},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib243","first-page":"1077","article-title":"Effect of Janus kinase inhibitors on T cell responses to herpes zoster in rheumatoid arthritis patients","volume":"41","author":"Lee","year":"2023","journal-title":"Clin. Exp. Rheuma"},{"issue":"12","key":"10.1016\/j.biopha.2024.116440_bib244","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41584-020-00535-5","article-title":"JAK1 inhibitor superior to abatacept in head-to-head RA trial","volume":"16","author":"Onuora","year":"2020","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.biopha.2024.116440_bib245","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/356040","article-title":"Regulatory effect of Iguratimod on the Balance of Th Subsets and Inhibition of Inflammatory Cytokines in Patients with Rheumatoid Arthritis","volume":"2015","author":"Xu","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"5","key":"10.1016\/j.biopha.2024.116440_bib246","doi-asserted-by":"crossref","DOI":"10.3390\/life11050457","article-title":"Iguratimod: novel molecular insights and a new csDMARD for Rheumatoid Arthritis, from Japan to the World","volume":"11","author":"Nozaki","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.biopha.2024.116440_bib247","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fphar.2020.00073","article-title":"Iguratimod as a new drug for rheumatoid arthritis: current landscape","volume":"11","author":"Xie","year":"2020","journal-title":"Front Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2024.116440_bib248","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.3892\/mmr.2017.6484","article-title":"Anti\u2011inflammatory effects of oxymatrine on rheumatoid arthritis in rats via regulating the imbalance between Treg and Th17 cells.","volume":"15","author":"Ma","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2024.116440_bib249","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/med.21762","article-title":"Tripterygium wilfordii: an inspiring resource for rheumatoid arthritis treatment","volume":"41","author":"Zhang","year":"2021","journal-title":"Med Res Rev."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222400324X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222400324X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:04:59Z","timestamp":1782342299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222400324X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":249,"alternative-id":["S075333222400324X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116440","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the therapeutic potential of regulatory T cell in rheumatoid arthritis: Insights into subsets, markers, and signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116440"}}